Patents by Inventor Narendra D. Lalwani

Narendra D. Lalwani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical Formulations, Methods, and Dosing Regimens for the Treatment and Prevention of Acute Coronary Syndromes
    Publication number: 20080293633
    Abstract: The invention provides methods and formulations for treating and preventing acute coronary syndromes. The methods of the instant invention provide safe and effective doses of an Apolipoprotein A-I Milano: phospholipid complex to reduce and stabilize atherosclerotic plaque. Pharmaceutical formulations of the Apo A-I Milano:phospholipid complexes are also provided.
    Type: Application
    Filed: October 30, 2007
    Publication date: November 27, 2008
    Inventors: Charles L. Bisgaier, Narendra D. Lalwani, Wendi V. Rodrigueza, Daniel Hartman, Jan Johansson
  • Pharmaceutical formulations, methods, and dosing regimens for the treatment and prevention of acute coronary syndromes
    Patent number: 7435717
    Abstract: The invention provides methods and formulations for treating and preventing acute coronary syndromes. The methods of the instant invention provide safe and effective doses of an Apolipoprotein A-I Milano:phospholipid complex to reduce and stabilize atherosclerotic plaque. Pharmaceutical formulations of the Apo A-I Milano:phospholipid complexes are also provided.
    Type: Grant
    Filed: October 15, 2004
    Date of Patent: October 14, 2008
    Assignee: Pfizer Inc.
    Inventors: Charles L. Bisgaier, Narendra D. Lalwani, Wendi V. Rodrigueza, Daniel Hartman, Jan Johansson
  • Methods of using non-human animal Apolipoprotein A-I protein
    Patent number: 6953840
    Abstract: The invention provides methods and compositions for treating disorders using non-human animal Apolipoprotein A-I (ApoA-I) protein. The invention provides methods and compositions for treating disorders in animals, including humans, associated with dyslipidemia, including hyperlipidemia, hyperlipoproteinemia, hypertriglyceridemia, hypercholesterolemia, HDL deficiency, ApoA-I deficiency, cardiovascular disease, atherosclerosis, restenosis, and other disorders such as septic shock and viral infections.
    Type: Grant
    Filed: July 29, 2003
    Date of Patent: October 11, 2005
    Assignee: Esperion Therapeutics, Inc.
    Inventors: Lingyu Zhu, Narendra D. Lalwani, Jean-Louis Dasseux
  • Methods of using non-human animal Apolipoprotein A-I protein
    Publication number: 20040077541
    Abstract: The invention provides methods and compositions for treating disorders using non-human animal Apolipoprotein A-I (ApoA-I) protein. The invention provides methods and compositions for treating disorders in animals, including humans, associated with dyslipidemia, including hyperlipidemia, hyperlipoproteinemia, hypertriglyceridemia, hypercholesterolemia, HDL deficiency, ApoA-I deficiency, cardiovascular disease, atherosclerosis, restenosis, and other disorders such as septic shock and viral infections.
    Type: Application
    Filed: July 29, 2003
    Publication date: April 22, 2004
    Inventors: Lingyu Zhu, Narendra D. Lalwani, Jean-Louis Dasseux